|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the HLTH 8-K filed Jul 2, 2009. Warrants
At December 31, 2008, the Company had warrants outstanding
to purchase 22,466 shares of its common stock at an
exercise price of $30.00 per share. These warrants are all
vested and exercisable. Warrants to purchase 14,772 shares
will expire in January 2009 and the remaining warrants to
purchase 7,694 shares will expire in January 2010.
Table of Contents
HLTH
CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS — (Continued)
During 2008, the Company repurchased a warrant for $700, which
was exercisable into 2,408,908 shares of its common stock
at an exercise price of $9.25 per share. During 2007, warrants
to purchase a total of 4,971 shares, of the Company’s
Common Stock at a weighted average exercise price of $6.43 per
share were exercised. There were no exercises of warrants during
2008 and 2006. Also during 2008, 2007 and 2006, warrants to
purchase a total of 9,464 shares, 3,014,229 shares and
100,000 shares, of the Company’s Common Stock at a
weighted average price of $30.00 per share, $15.03 per share and
$38.13 per share, respectively, expired.
These excerpts taken from the HLTH 10-K filed Mar 2, 2009. Warrants
At December 31, 2008, the Company had warrants outstanding
to purchase 22,466 shares of its common stock at an
exercise price of $30.00 per share. These warrants are all
vested and exercisable. Warrants to purchase 14,772 shares
will expire in January 2009 and the remaining warrants to
purchase 7,694 shares will expire in January 2010.
Table of Contents
HLTH
CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS — (Continued)
During 2008, the Company repurchased a warrant for $700, which
was exercisable into 2,408,908 shares of its common stock
at an exercise price of $9.25 per share. During 2007, warrants
to purchase a total of 4,971 shares, of the Company’s
Common Stock at a weighted average exercise price of $6.43 per
share were exercised. There were no exercises of warrants during
2008 and 2006. Also during 2008, 2007 and 2006, warrants to
purchase a total of 9,464 shares, 3,014,229 shares and
100,000 shares, of the Company’s Common Stock at a
weighted average price of $30.00 per share, $15.03 per share and
$38.13 per share, respectively, expired.
Warrants At December 31, 2008, the Company had warrants outstanding to purchase 22,466 shares of its common stock at an exercise price of $30.00 per share. These warrants are all vested and exercisable. Warrants to purchase 14,772 shares will expire in January 2009 and the remaining warrants to purchase 7,694 shares will expire in January 2010.
Table of ContentsHLTH CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) During 2008, the Company repurchased a warrant for $700, which was exercisable into 2,408,908 shares of its common stock at an exercise price of $9.25 per share. During 2007, warrants to purchase a total of 4,971 shares, of the Company’s Common Stock at a weighted average exercise price of $6.43 per share were exercised. There were no exercises of warrants during 2008 and 2006. Also during 2008, 2007 and 2006, warrants to purchase a total of 9,464 shares, 3,014,229 shares and 100,000 shares, of the Company’s Common Stock at a weighted average price of $30.00 per share, $15.03 per share and $38.13 per share, respectively, expired. This excerpt taken from the HLTH 10-K filed Aug 30, 2006. Warrants
The Company has warrants outstanding to purchase
5,560,038 shares of common stock which are all vested and
exercisable. The following table summarizes information with
respect to warrants outstanding at December 31, 2005:
During 2005, 2004 and 2003, warrants to purchase a total of
1,416,668 shares, 2,302,706 shares and
1,729,713 shares, of the Company’s common stock at a
weighted average exercise price of $1.53 per share,
$5.14 per share and $5.33 per share, respectively were
exercised. Also during 2005, 2004 and 2003, warrants to purchase
a total of 599,197 shares, 15,691,782 shares and
241,018 shares, of the Company’s common stock at a
weighted average price of $8.04 per share, $27.35 per
share and $11.43 per share, respectively, expired.
EMDEON
CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS —
(Continued)
This excerpt taken from the HLTH 10-K filed Mar 16, 2006. Warrants
The Company has warrants outstanding to purchase
5,560,038 shares of common stock which are all vested and
exercisable. The following table summarizes information with
respect to warrants outstanding at December 31, 2005:
During 2005, 2004 and 2003, warrants to purchase a total of
1,416,668 shares, 2,302,706 shares and
1,729,713 shares, of the Company’s common stock at a
weighted average exercise price of $1.53 per share,
$5.14 per share and $5.33 per share, respectively were
exercised. Also during 2005, 2004 and 2003, warrants to purchase
a total of 599,197 shares, 15,691,782 shares and
241,018 shares, of the Company’s common stock at a
weighted average price of $8.04 per share, $27.35 per
share and $11.43 per share, respectively, expired.
Table of Contents
EMDEON
CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS — (Continued)
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for HLTH: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
